Evidence map›Paper›PMID 25918957›Full record

ReviewCurrent opinion in infectious diseases2015

The roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infections.

Amy E Bryant, Clifford R Bayer, Michael J Aldape, Dennis L Stevens

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Familial Transmission of emm12 Group A Streptococcus.Emerging infectious diseases · 2017
    Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Amy E BryantaU.S. Department of Veterans Affairs, Office of Research and Development, Boise, Idaho bUniversity of Washington School of Medicine, Seattle, Washington, USA.
Clifford R Bayer
Michael J Aldape
Dennis L Stevens
United States Department of Veterans Affairs · USGTx (United States) · USVA Office of Research and Development · US

Funding

Women's health: interplay of maternal diet and key demographics on neurological health in the rural frontier and remote WestP20GM103408 · NIGMS · UNIVERSITY OF IDAHO · PI Kenneth A Cornell · 2012 to 2026
$59.8M
TRANSCRIPTIONAL ATTENUATION OF THE TYPE I INTERFERON RESPONSE BY RHINOVIRUSP20RR015587 · NCRR · UNIVERSITY OF IDAHO · PI BOHACH, GREGORY A · 2000 to 2009
$19.0M
Diagnosis of sub-clinical cryptic group A streptococcal myonecrosisR21AI101457 · NIAID · IDAHO VETERANS RESEARCH / EDUCATION FDN · PI BRYANT, AMY EVELYN · 2013 to 2014
$391k
Effects of NSAIDs on the genesis of streptococcal myonecrosis after traumaI01BX000395 · VA · BOISE VA MEDICAL CENTER · PI BRYANT, AMY EVELYN · 2009 to 2013
–
BLRD VA I01 BX000395Intramural VA VA999999NCRR NIH HHS P20 RR015587NIAID NIH HHS R21 AI101457NIGMS NIH HHS P20 GM103408NIGMS NIH HHS P20GM103408
6 · The paper itself

Abstract

purpose of reviewThis review summarizes clinical and basic science evidence linking trauma and nonsteroidal anti-inflammatory drug (NSAID) use to initiation and progression of severe group A streptococcal (GAS) soft tissue infection. RECENT

findingsNew evidence includes recent clinical series and controlled studies that lend support to an NSAID/GAS association, basic science studies that demonstrate unique roles for nonpenetrating injury and NSAID administration in initiation of cryptogenic GAS infection and experimental studies showing that nonselective NSAIDs accelerate disease progression and limit antibiotic efficacy in established GAS soft tissue infections. Potential mechanisms for these processes are discussed. SUMMARY: NSAIDs are important anti-inflammatory and analgesic drugs; however, new experimental data suggest that nonselective NSAIDs do more than simply mask the signs and symptoms of developing GAS infection. A more thorough understanding of the triadic interplay of injury-triggered immune signaling, GAS soft tissue infection and NSAIDs is of significant clinical importance and could shift the current paradigm of pain management to avert the consequences of such devastating infections.

Indexed as

AnimalsAnti-Bacterial AgentsAnti-Inflammatory Agents, Non-SteroidalDisease Models, AnimalDisease ProgressionHumansMicePainSeverity of Illness IndexSoft Tissue InfectionsStreptococcal InfectionsStreptococcus pyogenesTreatment OutcomeWounds, NonpenetratingAnti-Bacterial AgentsAnti-Inflammatory Agents, Non-Steroidal

Identifiers

PMID25918957
PMCPMC4775098
OpenAlexW2325678661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.